title: Chemotherapy treatment for older women with metastatic breast cancer: what is the evidence?
abstract: While the over-representation of the elderly in the breast cancer population is projected to dramatically increase within the next two decades, data on chemotherapy for elderly patients with metastatic breast carcinoma (MBC) remain very limited. The aim of the present study is to investigate whether elderly patients included in clinical studies for MBC are representative of the population seen during usual clinical practice. Firstly, a review of the literature was performed identifying 39 publications about chemotherapy for MBC focusing on elderly patients and we examined patient characteristics in each of these publications. Comparison of the age distribution of patients included in these studies with that of a large cohort of consecutive MBC patients aged 65years who received chemotherapy in our institution over the last ten years (n=573) indicated that trials tend to include relatively younger patients. Furthermore, criteria to assess external validity of the results are seldom reported. Possible ways to improve the applicability of results such as increasing the minimum age for inclusion and the use of CGA are proposed.
authors: Department of Medical Oncology, Institut Bergonié, South-West Comprehensive Cancer Center, Bordeaux Cedex, France. debled@bergonie.org
authors: Marc
authors: M
authors: Debled
authors: Carine
authors: C
authors: Bellera
authors: Catherine
authors: C
authors: Donamaria
authors: Pierre
authors: P
authors: Soubeyran